Plasma testosterone levels and ovarian testosterone content in adult mice treated with diethylstilbestrol neonatally

Abstract

Neonatal female NMRI mice ( n = 16) were treated with 5 μg diethylstilbestrol (DES) per day, for the first 5 days after birth and killed postpubertally. Control females ( n = 52) were injected with vehicle only and killed in different stages of the estrous cycle. The plasma testosterone level was significantly lower in DES females than in control females in any of the estrous phases. Ovariectomy ( n = 5), adrenalectomy ( n = 5) or a combination of both ablations ( n = 3) did not affect the plasma testosterone in DES treated females while it was significantly reduced in control females (ovariectomy n = 5; adrenalectomy n = 9); most effective was the combination ovariectomy-adrenalectomy ( n = 7). Ovarian homogenates from DES treated females ( n = 10) had a significantly lower testosterone content than homogenates from control females in any phase of the estrous cycle (6–10 females per phase), which held true on both a per ovary basis and when related to ovarian weight. After a 2 h incubation in vitro, the testosterone levels had increased significantly in DES homogenates ( n = 6) and to a lower extent in homogenates from control females in estrus ( n = 9). No similar effect was found in homogenates from diestrus ( n = 10) or proestrus ( n = 9) females. The results are discussed in relation to the special ovarian morphology of adult but neonatally DES treated females and also with respect to endocrine control mechanisms.